Stoxline.com

Stoxline Lite

Stoxline Pro

Option Calculator

iTourMap

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations | Stock Talks | Blogs | Newsletter

 

Click to view technical analysis chart 

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

27.66

Shares Float (M)

25.38

% Held by Insiders

3.45

% Held by Institutions

5.80

Shares Short (K)

1250

Shares Short Prior Month (K)

1280

Stock Basics & Statistics

EPS

-0.880

EPS Est. Current Year

-0.500

EPS Est. Next Year

-0.480

EPS Est. Next Quarter

-0.130

Forward EPS

Book Value (p.s.)

0.630

PEG Ratio

Profit Margin

Operating Margin

-931.64

Return on Assets (ttm)

-48.3

Return on Equity (ttm)

-150.9

Qtrly Rev. Growth

58.5

Gross Profit (p.s.)

0.046

Sales Per Share

0.051

EBITDA (p.s.)

-0.457

Qtrly Earnings Growth

Operating Cash Flow (M)

-13.07

Levered Free Cash Flow (M)

-7.27

Valuation

P/E

-1.74

P/E Growth Ratio

-0.03

P/BV

2.43

P/S

30.23

P/CF

-3.24

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-12-17

Last Split Ratio

0.25

 

Enter Stock Symbol:  

Opexa Therapeutics (OPXA)

1.53 -0.04 (-2.55%)

7/31/2014  4:00pm

Open:

1.57

Pre. Close:

1.57

High:

1.57

Low:

1.51

Volume:

45,532

Market Cap:

42.3M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.62 - 1.67

1.67 - 1.73

Low:

1.41 - 1.46

1.46 - 1.52

Close:

1.47 - 1.54

1.54 - 1.62

Technical analysis  (as of: 2014-07-31 4:35:13 PM)

Overall:

      

Stoxline rating system posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 1.89     One year: 2.01

Support:

Support1: 1.45    Support2: 1.21

Resistance:

Resistance1: 1.62    Resistance2: 1.72

Pivot:

1.57

Moving Averages:

MA(5): 1.58     MA(20): 1.58

MA(100): 1.64     MA(250): 1.74

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 58.73     %D(3): 66.73

RSI:

RSI(14): 41.93

52-Week:

High: 3.70  Low: 1.25  Change(%): 7.0

Average Vol(K):

3-Month: 190  10-Days 92

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
OPXA has closed above bottom band by 20.6%. Bollinger Bands are 53.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to OPXA's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 17 Jul 2014 14:48:45 GMT
RedChip Issues Research Profile on Opexa Therapeutics

Mon, 14 Jul 2014 10:52:30 GMT
Hot News – SolarCity Corp (NASDAQ:SCTY), Opexa Therapeutics Inc (NASDAQ ...

Tue, 08 Jul 2014 15:22:30 GMT
RedChip's July 16-17 Global Online CEO Conference Presentation Schedule ...

Mon, 23 Dec 2013 15:18:00 GMT
Opexa Therapeutics Inc announces closing of public offering of common stock

Tue, 17 Dec 2013 21:33:00 GMT
Opexa Therapeutics Inc announces proposed public offering of common stock

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

 
iTouMap

Nova Stocks

Share your ideas ...
Find hot stocks ...

 

(c) 2006-2013 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.